Literature DB >> 18160575

Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.

Satoshi Ota1, Hideo Wada, Yasunori Abe, Eri Yamada, Akane Sakaguchi, Junji Nishioka, Tsuyoshi Hatada, Ken Ishikura, Norikazu Yamada, Akihiro Sudo, Atsumasa Uchida, Tsutomu Nobori.   

Abstract

Prothrombin fragment 1 + 2 (F1 + 2) is considered to be useful for diagnosis of thrombosis. However, the evidence for a diagnosis of thrombosis by F1 + 2 is still not well established. The plasma concentrations of F1 + 2, soluble fibrin, D-dimer, and thrombin-antithrombin complex were measured in 694 patients suspected of having thrombosis and then were correlated with thrombosis. Plasma concentrations of F1 + 2, soluble fibrin, D-dimer, and thrombin-antithrombin complex were significantly higher in patients with thrombosis, compared with patients without thrombosis. When cutoff values of more than 300 pmol/L for F1 + 2 were used for the diagnosis, more than 50% of the patients were thus found to have thrombosis. The findings showed that F1 + 2, soluble fibrin, D-dimer, and thrombin-antithrombin complex have similar diagnostic ability. The plasma concentration of F1 + 2 closely was well correlated with thrombin-antithrombin complex, soluble fibrin, and D-dimer. Finally, F1 + 2 is one of the most useful parameters for the diagnosis of thrombosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160575     DOI: 10.1177/1076029607309176

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  18 in total

1.  Prothrombin fragment 1+2 as a sensitive marker of intraventricular thrombus formation in a patient with dilated cardiomyopathy: comparison with echocardiography.

Authors:  Takako Ishigaki; Takashi Yoshida; Hiroko Okuno; Yoshihisa Fujisawa; Shoko Shimizu; Shizuo Isogawa; Hidetoshi Okabe; Satoshi Nakatani
Journal:  J Echocardiogr       Date:  2012-12-02

2.  Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood.

Authors:  Anub M Thomas; Alexandra Gerogianni; Martin B McAdam; Yngvar Fløisand; Corinna Lau; Terje Espevik; Per H Nilsson; Tom Eirik Mollnes; Andreas Barratt-Due
Journal:  J Immunol       Date:  2019-08-14       Impact factor: 5.422

3.  An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow.

Authors:  Wei Yin; Andrew Dimatteo; Andrew Kumpfbeck; Stephen Leung; Marina Fandaros; Bryan Musmacker; David A Rubenstein; Mary D Frame
Journal:  Thromb J       Date:  2022-05-25

Review 4.  Biomolecular markers of cancer-associated thromboembolism.

Authors:  Diana L Hanna; Richard H White; Ted Wun
Journal:  Crit Rev Oncol Hematol       Date:  2013-03-21       Impact factor: 6.312

5.  Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass.

Authors:  Ruwan Gunaratne; Shekhar Kumar; James W Frederiksen; Steven Stayrook; Jens L Lohrmann; Kay Perry; Kristin M Bompiani; Charlene V Chabata; Nabil K Thalji; Michelle D Ho; Gowthami Arepally; Rodney M Camire; Sriram Krishnaswamy; Bruce A Sullenger
Journal:  Nat Biotechnol       Date:  2018-06-04       Impact factor: 54.908

6.  Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy.

Authors:  Marek Z Wojtukiewicz; Marta Mysliwiec; Elwira Matuszewska; Stanislaw Sulkowski; Lech Zimnoch; Barbara Politynska; Anna M Wojtukiewicz; Stephanie C Tucker; Kenneth V Honn
Journal:  Biomolecules       Date:  2021-04-29

7.  Paroxysmal Atrial Fibrillation: An Independent Risk Factor for Prothrombotic Conditions.

Authors:  Mariya Negreva; Krasimira Prodanova; Ana Zarkova
Journal:  J Atr Fibrillation       Date:  2020-08-31

8.  Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps.

Authors:  Ping-Ping Cao; Bao-Feng Wang; James E Norton; Lydia A Suh; Roderick G Carter; Whitney W Stevens; Anna G Staudacher; Julia H Huang; Kathryn E Hulse; Anju T Peters; Leslie C Grammer; David B Conley; Kevin C Welch; Robert C Kern; Zheng Liu; Jingying Ye; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2022-03-07       Impact factor: 14.290

9.  Risk factors for deep vein thrombosis of lower extremities in Sudanese women.

Authors:  Nadir Ahmed Ibrahim; Fathelrahman M Hassan; Mahmoud Mohamed Elgari; Sana Eltahir Abdalla
Journal:  Vasc Health Risk Manag       Date:  2018-08-20

10.  Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion.

Authors:  Heiko Rühl; Christina Berens; Anna Winterhagen; Jens Müller; Johannes Oldenburg; Bernd Pötzsch
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.